Big Pharmas remain cautious using social media
A recent survey by Deloitte shows that big pharmas are still relunctant to engage massively into social media.
The use of social networks has exploded over the past few years:
- one in three Americans research their condition online use social networks
- 60% of physicians are using or are interested in using social networks for professional purposes
- SERMO, the dedicated SN for physicians, is a real success
Anyway, life sciences companies lag firms in other industries in their social networks presence. Only 11% of Pharmaceuticals Fortune100 are on Facebook; 33% have blogs; and 22% are on Twitter.
Currently, half of surveyed life sciences professionals do not have plans to use social networks.
#1 Respondents perceive lack of regulatory guidance (from FDA) as the biggest barrier to adoption
#2 Patients’/consumers’ wish for privacy
#3 Lack of demonstrable Return on Investment
To Friend or not? New insights about social networks in the Life science industry. Deloitte, white paper. Dec. 2010. Online: